Keywords: Hyperglycemia; Placenta; Inflammatory cytokines; Inflammasome; IL-1β; interleukin-1β; IL-6; interleukin-6; MCP-1; monocyte chemoattractant protein-1; TNF-α; tumor necrosis factor alpha; IL-10; interleukin 10; iNOS; inducible nitric oxide synthase; TLR;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANNA; anti-neuronal nuclear antibody; APS; antiphospholipid syndrome; ARHGAP26; Ca/RhoGTPase-activating protein 26; CaMKII; calcium calmodulin-dependent protein kinase II; CASPR2; contactin-asso
Keywords: Myotonic dystrophy; DM1; Falls; Fractures; Balance;
Keywords: Factor analysis; Neuromuscular diseases; Outcome measure; Psychometrics; CMT; Charcot-Marie-Tooth disease; CFA; confirmatory factor analysis; D1; standing position and transfers; D2; axial and proximal motor function; D3; distal motor function; DM1; myoto
Keywords: Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: ADA; antidrug antibody; ALI/ARDS; acute lung injury/acute respiratory distress syndromes; Ab; antibody; ADC; antibody drug conjugate; ADCC; antigen-dependent cellular cytotoxicity; BAL; bronchoalveolar lavage; BsAbs; bispecific antibodies; CCL; CC chemoki
Keywords: Childhood myotonic dystrophy; Clinical evolution; Clinical manifestations; Excessive daytime sleepiness; Quality of life; CDM1; Congenital Myotonic Dystrophy; DM1; Myotonic Dystrophy Type 1; DMPK; Dystrophia Myotonica protein kinase; ESS; Epworth Sleepine
Keywords: TNR; trinucleotide repeat; HR; homologous recombination; EJ; end joining; DSB; double stranded break; SCR; sister chromatid recombination; NHEJ; non homologous end-joining; MMEJ; microhomology-mediated end-joining; DM1; myotonic Dystrophy type I; HD; Hunt
Keywords: DM1; diabetes mellitus type 1; DTTP; diabetes treatment and teaching programme; HbA1c; glycated haemoglobin; Insulin dose self-adjustment; Type 1 diabetes; Diabetes treatment and teaching programme;
Keywords: CSII; continuous subcutaneous insulin infusion; DM1; diabetes mellitus type 1; HbA1c; glycated haemoglobin; ICT; intensified conventional insulin therapy; ISA; insulin dose self-adjustment; Self-adjustment of insulin dose; Diabetes mellitus type 1;
Keywords: MR imaging; VBM; TBSS; DM1; Neuropsychology
Keywords: Myotonic dystrophy; Respiratory care; Non-invasive ventilation; Prospective cohort; Compliance; BIPAP; biphasic intermittent positive airway pressure; BMI; body mass index; CO2; carbon dioxide in arterial blood; CTG; cytosine-thymine-guanine; DM1; dys
Keywords: MMR; mismatch repair; MSH; mutS homolog; MLH; mutL homolog; BER; base excision repair; NER; nucleotide excision repair; TNR; trinucleotide repeat; DM1; myotonic dystrophy type 1; HD; huntington's disease; FRDA; Friedreich's ataxia; FXD; fragile X dise
Keywords: ACI; anemia of chronic inflammation; AD[H]D; attention deficit[/hyperactivity] disorder; ASD; autism spectrum disorder; BMS; burning mouth syndrome; BPAD; bipolar affective disorder; CCS; Cronkhite-Canada syndrome; CFS; chronic fatigue syndrome; CGRP; cal
Keywords: Myotonic dystrophy; Rehabilitation; Social participation; Muscle strength; Homecare services; Cut-off scores; AUC; area under curve; ROC; receiver operating characteristic; CTG; cytosine-thymine-guanine; DM1; myotonic dystrophy type 1; LIFE-H; Assessment
Keywords: SD; sustainable development; SQOL; social-quality of life; ECON; economic development; ENV; environmental protection; SDI; sustainable development index; DM1; a member from local authorities; DM2; a member from neighborhood community; DM3; a member from N
Keywords: Myotonic dystrophy; DM1; DM2; Aberrant isoform expression; Missplicing;
Keywords: AD; anaerobic digestion; CBP; cumulative biogas production; C/N; carbon-to-nitrogen ratio; DBP; daily biogas production; DM; dairy manure; DM1; dairy manure with photo-dark fermentation condition; DM2; dairy manure under dark fermentation condition; PM; p
Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes
Keywords: DM1; Type 1 diabetes; DM2; Type 2 diabetes; CGM; Continuos glucose monitoring; TDD; total daily insulin dose; BMI; Body mass index; IQR; interquartile range; SD; Standard deviation; A1c; Glycated hemoglobin; CV; coefficient of variation; MAG; mean absolut
Incidence of amplification failure in DMPK allele due to allelic dropout event in a diagnostic laboratory
Keywords: DM1; myotonic dystrophy tipe 1; DMPK gene; dystrophia myotonica-protein kinase gene; TP-PCR; triplet-repeat primed polymerase chain reaction; SBA; Southern Blot analysis; Myotonic dystrophy type 1; Diagnostic error; TP-PCR technique; Interruptions;
Site-specific and hydrophilic ADCs through disulfide-bridged linker and branched PEG
Keywords: ADC; antibody-drug conjugates; MMAE; monomethyl auristatin E; DAR; dhrug-to-antibody ratio; DTT; ditiothreitol; TCEP; (tris(2-carboxyethyl)phosphine; T-DM1; Trastuzumab emtansine; DM1; Mertansine; SMCC; Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-ca
Heat shock protein B1 is required for the prolactin-induced cytoprotective effects on pancreatic islets
Keywords: Apoptosis; Diabetes; Human islets; Islet transplantation; Prolactin; Survival; Mouse islets; AG490; Tyrphostin AG490; BAX; BCL2-associated X protein; BCL2; B cell CLL/lymphoma 2; BCLxL; BCL extra large; DM1; Type 1 diabetes mellitus; FCS; Fetal calf serun
Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes
Keywords: Myotonic Dystrophy type 1 (DM1); Human induced pluripotent stem cells; Cardiomyocytes; Electrophysiological analysis; Antiarrhytmic drugs; ACTN2; sarcomeric alpha actinin; AFM; atomic force microscopy; AP; action potential; APD; action potential duration;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Left ventricular longitudinal strain impairment predicts cardiovascular events in asymptomatic type 1 myotonic dystrophy
Keywords: CTG; Cytosine-Thymine-Guanine; DM1; myotonic dystrophy type 1; ECG; electrocardiogram; GLS; global longitudinal strain; LVEF; left ventricular ejection fraction; LS; longitudinal strain; Myotonic dystrophy type 1; Left ventricular function; Echocardiograp
ReviewDiscriminating RNA variants with single-molecule allele-specific FISH
Keywords: FISH; Fluorescence in situ hybridization; smFISH; single-molecule FISH; SNP; single nucleotide polymorphism; DM1; myotonic dystrophy type 1; Allele-specific; Point mutation; Splicing; Fused gene; Fluorescence in situ hybridization; Single molecule detecti
The cognitive profile of myotonic dystrophy type 1:Â A systematic review and meta-analysis
Keywords: Cognitive disorders; Trinucleotide repeat diseases; Muscle disease; DM1; myotonic dystrophy type 1;
Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro
Keywords: ADA; adenosine deaminase; CBA; cytometric bead array; Cmax; maximum concentration; DC; dendritic cells; DM1; type 1 diabetes mellitus; DPP-4; dipeptidyl peptidase-4; EGR2; early growth response 2; FBS; fetal bovine serum; GIP; glucose-dependent insulinotr
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Keywords: Castration-resistant prostate cancer; DM1; Maytansinoid; MLN2704; Multiple ascending dose; PSMA;
Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways
Keywords: DM1; Curcumin analog; Peritonitis; Edema; Anti-inflammatory; iNOS; COX-2; Autophagy
Haplotype analysis and LD detection at DM1 locus
Keywords: DM1; Myotonic dystrophy type 1; DMPK; Dystrophia myotonica protein kinase gene; SNPs; Single nucleotide polymorphisms; LD; Linkage disequilibrium; Myotonic dystrophy type 1 (DM1); DMPK gene; Haplotype; HhaI; HinfI; BpmI; CKMM; Linkage disequilibrium (LD);
DNA mismatch repair enzymes: Genetic defects and autoimmunity
Keywords: AA; aplastic anemia; ARS; aminoacyl tRNA synthetase; CMMR-D; constitutional mismatch repair-deficiency syndrome; DM; dermatomyositis; DM1; myotonic dystrophy type I; DNA-PKcs; DNA-dependent protein kinase; ELISA; enzyme-linked immunosorbent assay; HD; Hun
Aging and a long-term diabetes mellitus increase expression of 1 α-hydroxylase and vitamin D receptors in the rat liver
Keywords: DM; diabetes mellitus; VDR; vitamin D receptor; 1α-OHase; 1 α-hydroxylase; DM1; diabetes mellitus type 1; RXR; retinoid X receptors; STZ; streptozotocin; DAPI; 4â²,6-diamidino-2-phenylindole; PBS; phosphate buffer saline; SD; standard deviation; GFAP;
Age-, tissue- and length-dependent bidirectional somatic CAGâ¢CTG repeat instability in an allelic series of R6/2 Huntington disease mice
Keywords: HD; Huntington disease; DM; myotonic dystrophy; DM1; myotonic dystrophy type 1; PCR; polymerase chain reaction; YAC; yeast artificial chromosome; BAC; bacterial artificial chromosome; SP-PCR; small pool-PCR; SCA1; spinocerebellar ataxia type 1; SCA7; spin
Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets - Results of one year follow-up
Keywords: anti-GAD; glutamic acid decarboxylase autoantibodies; anti-IA2; tyrosine phosphatase-related islet antigen 2 autoantibodies; b.w; body weight; cGMP; current good manufacturing practice; DDI; daily dose of insulin; DM1; type 1 diabetes mellitus; GvHD; graf
GuÃa de práctica clÃnica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes
Keywords: GuÃas de Práctica ClÃnica; Diabetes mellitus; Enfermedad cardiovascular; Intolerancia a la glucosa; Manejo del paciente; Prevención; EpidemiologÃa; Pronóstico; Diagnóstico; Factores de riesgo; Tratamiento farmacológico; Intervenciones coronarias;
CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease
Keywords: CELF; CUG-BP, Elav-like family; DM1; Myotonic dystrophy type 1; MBNL; Muscle blind-like; SCA; Spinocerebellar ataxia; SMA; Spinal muscular atrophy; SMN; Survival motor neuron; SBMA; Spinal and bulbar muscular atrophy; CLIP; Crosslinking immunoprecipitatio
Targeting long non-coding RNAs in cancers: Progress and prospects
Keywords: ANRIL; antisense non-coding RNA in the INK4 locus; ATRA; all-trans retinoic acid; ASO; antisense oligonucleotide; CRC; colorectal carcinoma; CREB; cAMP-responsive element binding protein; DM1; myotonic dystrophy type 1; DsRNA; double-stranded RNA; EMT; ep
Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus
Keywords: DM1; DM2; Expansion; Myotonic dystrophy; Uninterrupted repeats; CNBP
Regulation of the alternative splicing of sarcoplasmic reticulum Ca2+-ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway
Keywords: SERCA1; sarcoplasmic reticulum Ca2+-ATPase1; PMA; phorbol 12-myristate 13-acetate; DM1; myotonic dystrophy type 1; DMPK; myotonic dystrophy protein kinase; MBNL1; muscleblind-like protein 1; CUGBP1; CUG-binding protein 1; CELF; CUG-BP and ETR-3-like (embr
Treatment with Azadirachta indica in diabetic pregnant rats: Negative effects on maternal outcome
Keywords: APA; appropriate for pregnancy age; AUC; area under the curve; CHO; total cholesterol; D; diabetic non-treated; DM; diabetes mellitus; DM1; type 1 diabetes mellitus; DOil; diabetic treated with seed oil neem; DPA; diabetic treated with azadirachtin; GSH-P
Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy
Keywords: DM; Myotonic dystrophy; DM1; Myotonic dystrophy type 1; cDM1; Congenital myotonic dystrophy type 1; DM2; Myotonic dystrophy type 2; DM1exp; DM1 cells carrying (CTG)n alleles where n > 3000; PGE2; Prostaglandin E2; PGF2; Prostaglandin F2; EP; E-prostanoi
Cerebral and muscle MRI abnormalities in myotonic dystrophy
Keywords: Myotonic dystrophy; DM; DM1; DM2; Diffusion tensor imaging; Magnetic resonance imaging; MRI; Cerebral white matter; Cerebral gray matter; Craniofacial muscle; Pterygoid; Temporalis; Masseter;
Neurodegeneration the RNA way
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; Aβ42; amyloid β - 42 amino acids; CUGBP1; CUG binding protein 1; DM1; myotonic dystrophy type 1; DM2; myotonic dystrophy type 2; FTD; frontotemporal dementia;
IgG deficiency and expansion of CTG repeats in myotonic dystrophy
Keywords: DM1; myotonic dystrophy type I; DMPK; myotonic dystrophy protein kinase; FcRn; fragment c Receptor neonatal; IgA; immunoglobulin A; IgG; immunoglobulin G; IgGm; immunoglobulin G subclass m; IgM; immunoglobulin M; MHC; major histocompatibility; PaO2; arter
Low Levels of Asymmetric Dimethylarginine in Children with Diabetes Mellitus Type I Compared with Healthy Children
Keywords: ADMA; Asymmetric dimethylarginine; BP; Blood pressure; BMI; Body mass index; DDAH; Dimethylarginine dimethylaminohydrolase; DM1; Diabetes mellitus type 1; HDL; High-density lipoprotein; HbA1c; Hemoglobin A1c; NO; Nitric oxide; NOS; Nitric oxide synthase;
Antibody-DM1 conjugates as cancer therapeutics
Keywords: Maytansinoid; DM1; Microtubule; Cancer; Tubulin
Arginine vasotocin neuronal phenotypes, telencephalic fiber varicosities, and social behavior in butterflyfishes (Chaetodontidae): Potential similarities to birds and mammals
Keywords: BA; basal amygdala; BNST; bed nucleus of stria terminalis; Dc2; central part of the dorsal telencephalon, subdivision 2; Dd; dorsal part of the dorsal telencephalon; Dld; dorsal division of lateral part of the dorsal telencephalon; Dlv; ventral division o
Dystrofia miotoniczna – nowe spojrzenie na znaną chorobę
Keywords: dystrofia miotoniczna; DM1; DM2; mutacja dynamiczna; RNA; składanie genówmyotonic dystrophy; DM1; DM2; dynamic mutation; RNA; splicing
Length-dependent toxicity of untranslated CUG repeats on Caenorhabditis elegans
Keywords: DM1; CUG repeats; Transgenic C. elegans